AIMS Biosciences Project Manager Visits RMI CTU

AIMS Biosciences Project Manager Visits RMI CTU

Chen Xhin Hui, Project Manager of Aims Biosciences, visited RMI’s Clinical Trials Unit (CTU) for monitoring, quality control, and audit of the ongoing trials.

She was very impressed with the quality of work, ethical standards, and patient-centered approach of the CTU. Ms. Hui was received and briefed by CTU head Dr. Sajjad Ali and Associate Manager Mohsin Hassan. She then visited various sections of the CTU, including the data management center, the clinical laboratory, pharmacy, and other facilities.

She interacted with the staff members and inquired about the various aspects of clinical trial operations. Ms. Hui was highly impressed with the quality of work at the CTU and commended the staff for their dedication and commitment to patient safety and well-being. She also expressed her interest in future collaborations with the CTU. Other CTU staff members and officials of Metrics Research were present during her visit.

The visit of Ms. Hui to the CTU was a valuable opportunity for the two organisations to learn from each other and explore ways to collaborate in the future.

Related Stories

COVID-19 Booster Dose 

A Multi-center, Randomized, Blinded, Placebo-controlled, Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) as Booster in

Read More

COVID-19 Treatment

A Phase 3, multicenter, randomized, double-blind, 48-week study of the clinical and antiviral effect of S 217622 compared with placebo in non-hospitalized high risk participants

Read More

Trials in Pipeline

Trial Name Disease Area CML Oncology Breast cancer Oncology CABG Cardiology Fungal infection evaluation Infectious Diseases Alzheimer’s Disease Neurology Alkylosing Spondyloarthritis Rheumatology Advanced Melanoma Oncology

Read More